All Episodes
|
167
|
Bill Lane

Podcast 167: Why Accountable Care Models Are So Important w/ Bill Lane

May 14, 2024

Episode Summary

Having equal access to quality health care across the United States shouldn't be a privilege, but a reality. Yet, seniors battling multiple chronic conditions often face disparities. The challenges are significant, from struggling to reach appointments to affording basic needs.Enter Accountable Care Organizations (ACOs).  Are they the answer to improving coordinated care and reducing costs for seniors?In this episode of Health Care Rounds, Bill Lane joins John to explore how Accountable Care Organizations (ACOs) are transforming health care delivery, particularly for seniors.

Episode Notes

Having equal access to quality health care across the United States shouldn't be a privilege, but a reality. Yet, seniors battling multiple chronic conditions often face disparities. The challenges are significant, from struggling to reach appointments to affording basic needs.

Enter Accountable Care Organizations (ACOs).  Are they the answer to improving coordinated care and reducing costs for seniors?

In this episode of Health Care Rounds, Bill Lane joins John to explore how Accountable Care Organizations (ACOs) are transforming health care delivery, particularly for seniors.

ABOUT HEALTH CARE ROUNDS

Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in healthcare business news and policy developments.

ABOUT BILL LANE

Bill is ilumed’s Executive Vice President of Network Development, leading the ACO REACH’s contracted provider and beneficiary growth over 200% from 2022 to 2024. Prior to ilumed, he spent over 15 years with Humana and held leadership roles in hospital/hospital system contracting, alternative payment model creation and deployment, including the nationwide lead for Humana’s adoption of CMS’ Primary Care First model. Before Humana, Bill was with the national PPO, MultiPlan for over ten years, where he held progressively responsible network leadership roles in the southeast.

Bill and his wife of 32 years, Kathy, live in south Florida, where he enjoys golf most of the time and looks forward to welcoming his three grown children home as much as possible.

ABOUT JOHN MARCHICA, HOST OF HEALTH CARE ROUNDS

John Marchica is a veteran health care strategist and CEO of Darwin Research Group, a strategic consulting and market intelligence firm focused on hospitals, health systems, physician groups, and the evolving health care ecosystem. John has a degree in economics from Knox College, an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Health care Executives and is pursuing certification as a Fellow.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

Recommended Content

Browse Library
INsights
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Read More
INsights
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read More
INsights
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.